Comparative study of ceftibuten and cefixime in the treatment of complicated urinary tract infections

Journal of Microbiology, Immunology and Infection

Volumn 34, Issue 3, 2001, Pages 185-189

  Ho, M W ^a   Wang, F D ^a   Fung, C P ^a   Liu, C Y ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Cefixime; Ceftibuten; Complicated urinary tract infection

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEFIXIME; CEFTIBUTEN; CEPHALOSPORIN DERIVATIVE;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; BLADDER CATHETERIZATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SAFETY; ESCHERICHIA COLI; FEMALE; GRAM NEGATIVE INFECTION; HUMAN; KLEBSIELLA PNEUMONIAE; LIVER TOXICITY; MALE; NEUROGENIC BLADDER; PROSTATE HYPERTROPHY; PROTEUS MIRABILIS; RANDOMIZED CONTROLLED TRIAL; RASH; TREATMENT OUTCOME; URINARY TRACT INFECTION; UROLOGIC SURGERY;

ADULT; AGED; AGED, 80 AND OVER; CEFIXIME; CEPHALOSPORINS; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; TREATMENT OUTCOME; URINARY TRACT INFECTIONS;

EID: 0034791560     PISSN: 02532662     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. The new beta-lactamase-stable cephalosporins
2. Complicated urinary tract infections
3. Comparison of cefprozil, cefpodoxime proxetil, loracarbef, cefixime and ceftibuten
4. Ceftibuten: A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy
5. Cefixime in the treatment of acute lower respiratory tract and urinary tract infections
6. Ceftibuten: A review of antimicrobial activity, spectrum and other microbiologic features
7. Bacteriological evaluation of 7432-S, a new oral cephalosporin
8. In vitro and in vivo antibacterial activity of 7432-S
9. 7432-S, its in vitro antibacterial activity, affinity with bacterial penicillin-binding proteins (PBPs), and synergy of bactericidal effect with the serum complement or mouse cultured macrophages
10. Antibacterial activity of a new cephem, ceftibuten against anaerobic bacteria
11. In vitro and in vivo antibacterial activities of 7432-S, a new oral cephem antibiotic
12. Comparative susceptibility of clinical isolates producing extended spectrum beta-lactamases to ceftibuten: Effect of large inocula
13. Ceftibuten (7432-S, SCH 39720): Comparative antimicrobial activity against 4735 clinical isolates, beta-lactamase stability and broth microdilution quality control guidelines
14. Antibacterial activity of cefpodoxime in comparison with cefixime, cefdinir, ceftamet, ceftibuten, loracarbef, cefprozil, BAY3522, cefuroxime, cefaclor and cefadroxil
15. Treatment of acute uncomplicated urinary tract infection with ceftibuten
16. Clinical studies on 7432-S, a new oral cephem antibiotic, in urologcial infections
17. Clinical studies on 7432-S in the urological field
18. Recurrent urinary tract infections in men: An assessment of contemporary treatment
19. The efficacy and safety of once-daily ceftibuten compared with coamoxiclav in the treatment of acute bacterial sinusitis
20. Acute toxicity study of 7432-S and 7432-S-trans in rats and dogs
21. One month subacute toxicity study of 7432-S (ceftibuten), an oral cephem antibiotic, in rats
22. Nephrotoxicity study of 7432-S in rabbits
23. The effect of prescribed daily dose frequency on patient medication compliance
24. Strategies to improve compliance with therapy
25. Importance of patient compliance in effective antimicrobial therapy
26. Determinants of non-compliance with short term antibiotic regimen